Ads
related to: prostate cancer hormone therapy prognosis options treatment chart for women- Contact Us
Get in contact with a sales
representative.
- Downloadable Resources
Discover downloadable guides for
health care professionals.
- Imaging Site Locator
Locate an existing imaging site or
register a new imaging site.
- Sign Up for Updates
Sign up for updates including new
imaging locations and savings.
- Contact Us
Search results
Results from the WOW.Com Content Network
Management of prostate cancer. Treatment for prostate cancer may involve active surveillance, surgery, radiation therapy – including brachytherapy (prostate brachytherapy) and external-beam radiation therapy, proton therapy, high-intensity focused ultrasound (HIFU), cryosurgery, hormonal therapy, chemotherapy, or some combination.
Five-year survival rates range from 30–99%, depending on stage. [1] Prostate cancer is the uncontrolled growth of cells in the prostate, a gland in the male reproductive system below the bladder. Abnormal growth of prostate tissue is usually detected through screening tests, typically blood tests that check for prostate-specific antigen (PSA ...
Androgen deprivation therapy. Androgen deprivation therapy (ADT), also called androgen ablation therapy or androgen suppression therapy, is an antihormone therapy whose main use is in treating prostate cancer. Prostate cancer cells usually require androgen hormones, such as testosterone, to grow. ADT reduces the levels of androgen hormones ...
In Wikidata. High-dose estrogen therapy (HDE) is a type of hormone therapy in which high doses of estrogens are given. [1] When given in combination with a high dose of progestogen, it has been referred to as pseudopregnancy. [2][3][4][5] It is called this because the estrogen and progestogen levels achieved are in the range of the very high ...
Bicalutamide is used primarily in the treatment of early and advanced prostate cancer. [1] It is approved at a dosage of 50 mg/day as a combination therapy with a gonadotropin-releasing hormone analogue (GnRH analogue) or orchiectomy (that is, surgical or medical castration) in the treatment of stage D2 metastatic prostate cancer (mPC), [2] [3] and as a monotherapy at a dosage of 150 mg/day ...
A 2019 study looked into the diagnosis and treatment costs with Medicare for prostate cancer that has not spread to other parts of the body. Researchers estimated that for males 70 years old and ...
Ads
related to: prostate cancer hormone therapy prognosis options treatment chart for women